Executive Change: BioSkryb Genomics Appoints William Evans Pharm.D. as Chief Executive Officer

Durham, NC – BioSkryb Genomics has announced the appointment of William Evans as Chief Executive Officer. About BioSkryb Genomics: BioSkryb Genomics is a biotechnology company focused on single-cell analysis and ultra-low-input multiomic solutions. Its core technology is a patented whole genome amplification method called primary template-directed amplification (PTA), which the company says achieves 97% genome coverage and supports accurate, high-fidelity single-cell data. BioSkryb combines whole genome amplification with full-length transcriptome and surface protein analysis in a single-day, automation-compatible workflow, positioning itself as a provider of integrated tools for advanced molecular discovery. The company says its technology helps researchers and clinicians examine the genome, transcriptome, and proteome at single-cell resolution to better understand complex biology and disease. BioSkryb is also described on its site as a rapidly growing organization and a pioneer in single-cell and ultra-low-input multiomic solutions.

For more information visit: https://www.bioskryb.com/

BioSkryb Genomics
2810 Meridian Pkwy Suite 110
Durham, NC 27713
Phone: 919-370-0841
LinkedIn: https://www.linkedin.com/company/bioskryb

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved